Correlation Between Hepion Pharmaceuticals and Cns Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Hepion Pharmaceuticals and Cns Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Hepion Pharmaceuticals and Cns Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Hepion Pharmaceuticals and Cns Pharmaceuticals, you can compare the effects of market volatilities on Hepion Pharmaceuticals and Cns Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Hepion Pharmaceuticals with a short position of Cns Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Hepion Pharmaceuticals and Cns Pharmaceuticals.
Diversification Opportunities for Hepion Pharmaceuticals and Cns Pharmaceuticals
0.67 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Hepion and Cns is 0.67. Overlapping area represents the amount of risk that can be diversified away by holding Hepion Pharmaceuticals and Cns Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cns Pharmaceuticals and Hepion Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Hepion Pharmaceuticals are associated (or correlated) with Cns Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cns Pharmaceuticals has no effect on the direction of Hepion Pharmaceuticals i.e., Hepion Pharmaceuticals and Cns Pharmaceuticals go up and down completely randomly.
Pair Corralation between Hepion Pharmaceuticals and Cns Pharmaceuticals
Given the investment horizon of 90 days Hepion Pharmaceuticals is expected to generate 0.6 times more return on investment than Cns Pharmaceuticals. However, Hepion Pharmaceuticals is 1.67 times less risky than Cns Pharmaceuticals. It trades about -0.02 of its potential returns per unit of risk. Cns Pharmaceuticals is currently generating about -0.05 per unit of risk. If you would invest 754.00 in Hepion Pharmaceuticals on August 27, 2024 and sell it today you would lose (688.00) from holding Hepion Pharmaceuticals or give up 91.25% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Hepion Pharmaceuticals vs. Cns Pharmaceuticals
Performance |
| Timeline |
| Hepion Pharmaceuticals |
| Cns Pharmaceuticals |
Hepion Pharmaceuticals and Cns Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Hepion Pharmaceuticals and Cns Pharmaceuticals
The main advantage of trading using opposite Hepion Pharmaceuticals and Cns Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Hepion Pharmaceuticals position performs unexpectedly, Cns Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cns Pharmaceuticals will offset losses from the drop in Cns Pharmaceuticals' long position.| Hepion Pharmaceuticals vs. Enveric Biosciences | Hepion Pharmaceuticals vs. Elevation Oncology | Hepion Pharmaceuticals vs. Ocean Biomedical | Hepion Pharmaceuticals vs. Zura Bio Limited |
| Cns Pharmaceuticals vs. Capricor Therapeutics | Cns Pharmaceuticals vs. Soleno Therapeutics | Cns Pharmaceuticals vs. Bio Path Holdings | Cns Pharmaceuticals vs. Moleculin Biotech |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Complementary Tools
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |